Literature DB >> 8825787

beta-Casomorphin causes hypoalgesia in 10-day-old rats: evidence for central mediation.

E M Blass1, J Blom.   

Abstract

Two experiments determined behavioral effectiveness of beta-casomorphins (beta-CM) in 10-d-old rats by evaluating changes in heat escape latency from a 48 degrees C stimulus applied to a forepaw. In one study rats were injected systemically with beta-CM4, -5, or -7 at a dose range of 0.1-2.5 mg/kg. Only beta-CM5 was effective, and the dose-response relationship was graded. The second study evaluated the locus of action of beta-CM5 through two experimental manipulations: first, by injecting it (0.25 microgram) into the lateral ventricles and by attempting to block its effects with systemic injections of naloxone. Second, rats received intracerebroventricular injections of naloxone (0.25 microgram) and systemic injections of beta-CM. beta-CM was effective centrally, suggesting central detection of the drug. Naloxone injected into the lateral ventricles blocked the effects of systemic administration of beta-CM, implying that circulating beta-CM or their precursors cause behavioral change through central mechanisms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825787     DOI: 10.1203/00006450-199602000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Suckling and sucrose ingestion suppress persistent hyperalgesia and spinal Fos expression after forepaw inflammation in infant rats.

Authors:  K Ren; E M Blass; Q Zhou; R Dubner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 2.  Strategies for the prevention and management of neonatal and infant pain.

Authors:  Denise Harrison; Janet Yamada; Bonnie Stevens
Journal:  Curr Pain Headache Rep       Date:  2010-04

3.  Comparison the Effectiveness of Breastfeeding, Oral 25% Dextrose, Kangaroo-Mother Care Method, and EMLA Cream on Pain Score Level Following Heal Pick Sampling in Newborns: a randomized clinical trial.

Authors:  Soroosh Soltani; Dariush Zohoori; Mojtaba Adineh
Journal:  Electron Physician       Date:  2018-05-05

Review 4.  Casein and Peptides Derived from Casein as Antileukaemic Agents.

Authors:  Edgar Ledesma-Martínez; Itzen Aguíñiga-Sánchez; Benny Weiss-Steider; Ana Rocío Rivera-Martínez; Edelmiro Santiago-Osorio
Journal:  J Oncol       Date:  2019-09-08       Impact factor: 4.375

Review 5.  A1- and A2 beta-casein on health-related outcomes: a scoping review of animal studies.

Authors:  Daniela Kuellenberg de Gaudry; Szimonetta Lohner; Karin Bischoff; Christine Schmucker; Simone Hoerrlein; Christine Roeger; Lukas Schwingshackl; Joerg J Meerpohl
Journal:  Eur J Nutr       Date:  2021-06-01       Impact factor: 5.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.